Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

PAVmed Inc

PAVM
1,03
0,02 (1,98%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/11/202413:56PRNUSLucid Diagnostics Submits Clinical Evidence Package to MolDX..
18/11/202414:15PRNUSLucid Diagnostics to Present at the Canaccord Genuity..
14/11/202414:01PRNUSPAVmed Provides Business Update and Third Quarter 2024..
07/11/202414:01PRNUSLucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter..
05/11/202414:01PRNUSLucid Diagnostics Expands Direct Contracting Initiative with..
31/10/202413:31PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
30/10/202413:31PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
15/10/202413:51PRNUSLucid Diagnostics Receives Notice of Allowance for Key..
10/10/202413:51PRNUSPAVmed Subsidiary, Veris Health, Awarded $1.8 Million NIH..
09/10/202414:01PRNUSLucid Diagnostics to Participate in the 2024 Maxim..
08/10/202413:49PRNUSLucid Diagnostics to Join Global Medtech Leaders at The..
01/10/202414:01PRNUSLucid Diagnostics Holds Inaugural #CheckYourFoodTube..
24/9/202414:01PRNUSAmerican Foregut Society's 2024 Annual Meeting to Highlight..
16/9/202422:30PRNUSPAVmed Announces Efforts to Regain Compliance with Nasdaq..
10/9/202413:56PRNUSLucid Diagnostics to Host Symposium on Non-Endoscopic..
03/9/202413:51PRNUSLucid Diagnostics Signs Memorandum of Understanding with..
20/8/202414:16PRNUSLucid Diagnostics Announces Publication of Analytical..
13/8/202414:18EDGAR2Form 8-K - Current report
13/8/202414:16PRNUSThe American Foregut Society Formally Requests Medical..
13/8/202414:01PRNUSPAVmed Provides Business Update and Second Quarter 2024..
12/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:07PRNUSLucid Diagnostics Provides Business Update and Second..
08/8/202414:31PRNUSLucid Diagnostics Holds First Major Directly-Contracted..
06/8/202414:15PRNUSLucid Diagnostics Announces Positive Data from ENVET-BE..
05/8/202414:15PRNUSLucid Diagnostics to Participate in Upcoming Investor..
30/7/202414:15PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
29/7/202414:15PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
23/7/202414:01PRNUSLucid Diagnostics Announces Record Quarterly EsoGuard® Test..
11/7/202414:31PRNUSLucid Diagnostics Launches New Corporate Website
02/7/202413:55PRNUSLucid Diagnostics Announces Positive Data from its ESOGUARD..
13/6/202413:58PRNUSPAVmed Subsidiary, Veris Health, Announces Launch of Pilot..
12/6/202414:05PRNUS4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard®..
14/5/202402:43PRNUSPAVmed Provides Business Update and First Quarter 2024..
13/5/202414:00PRNUSLucid Diagnostics Provides Business Update and First Quarter..
09/5/202413:49PRNUSLegacy Sponge-on-a-String Esophageal Cell Collection Device..
07/5/202413:39PRNUSLucid Diagnostics Closes Series B / B-1 Preferred Stock..
03/5/202414:35PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
02/5/202414:35PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
02/5/202413:49PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
30/4/202413:35PRNUSPAVmed Subsidiary, Veris Health, Signs Memorandum of..
29/4/202414:47PRNUSLucid Diagnostics Partners with the Esophageal Cancer Action..
08/4/202414:30PRNUSLucid Diagnostics to Participate in Fireside Chat at the..
27/3/202400:32PRNUSPAVmed Provides Business Update and Fourth Quarter and Full..
21/3/202414:30PRNUSLucid Diagnostics Announces Positive Data from the First..
21/3/202413:30PRNUSPAVmed Launches Incubator to Advance Existing Pipeline..
20/3/202413:30PRNUSLucid Diagnostics Announces Multiple Presentations at the..
13/3/202413:30PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
12/3/202413:30PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
08/3/202422:30EDGAR2Form 8-K - Current report
23/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,00 Min: 0,99 Max: 1,05
Chiusura: 1,01

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network